1. Cost-Effectiveness Analysis of a Screening Program for Breast Cancer in Vietnam 
Lan Hoang Nguyen, Wongsa Laohasiriwong, John Frederick Stewart, Pamela Wright, Yen Thi Bach Nguyen, Peter C. Coyte 
Value in Health Regional Issues 
Volume 2, Issue 1, Pages (May 2013)
DOI: /j.vhri
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Model of natural course of breast cancer. I1-4 represents stage-specific incidence rate of breast cancer by absence of screening program and P1-4 represents stage-specific incidence rate of breast cancer by presence of screening program. Death from other causes is difference between overall mortality (M) and breast cancer-specific mortality (m1-4).
Value in Health Regional Issues 2013 2, 21-28DOI: ( /j.vhri )
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
2000 Monte Carlo simulations of incremental cost-effectiveness ratios plotted on a cost-effectiveness plane comparing screening program vs. no screening program.
Value in Health Regional Issues 2013 2, 21-28DOI: ( /j.vhri )
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3
Cost-effectiveness acceptability curve for breast cancer screening program in Vietnam (health care payer's perspective).
Value in Health Regional Issues 2013 2, 21-28DOI: ( /j.vhri )
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

5. Fig. 4
Result of univariate sensitivity analyses showing impact of key factors on ICERs for breast cancer screening program in Vietnam.
Value in Health Regional Issues 2013 2, 21-28DOI: ( /j.vhri )
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions